Newsroom

Press Releases

Koronis Pharmaceuticals' Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation (May 19, 2009)
READ MORE >>

Koronis Pharmaceuticals Announces Appointment of Prominent HIV Researcher Courtney Fletcher, Pharm. D., to Scientific Advisory Board and Jeff Parkins as VP, Clinical Development (September 30, 2008)
READ MORE >>

Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development (February 7, 2008)
READ MORE >>

Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors (January 31, 2008)
READ MORE >>

News Coverage

Genetic Engineering News: Need for Novel Approaches to Treating HIV Still Exists
Patricia F. Diamond, Ph.D., Genetic Engineering News, July 31, 2009

The New Virus Killer: Scientists try to turn HIV’s greatest strength—mutation—against itself
Gregory Mone, POPSCI.com, January 15, 2009

From Soup to Nuts
Drug Discovery & Development, April 01, 2008

Why Are Evolutionary Biologists Bringing Back Extinct Deadly Viruses?
The New Yorker, Annals of Science, Darwin’s Surprise, December 3, 2007

New Kind of Antiretroviral, KP-1461; Clinical Trial Recruiting
AIDS Treatment News, October 11, 2007

KP-1461 Novel Agent Enters Phase 2a Proof-of-Concept Study
Positively Aware, September/October 2007

Selected Articles

New HIV Drug Development a Problem
Jules Levin, December 4, 2008

2007 - A Look Back Over 20 Years
Mary Katz, MD, Being Alive Winter 2008 Newsletter

Stay Informed

To keep updated on Koronis' latest events and news releases, please go to our contact page and enter your name and email address to be added to our email news distribution list.